HOME › DRUGS › TIPRANAVIR
ACTIVE SUBSTANCE / INN

TIPRANAVIR

Brand name(s): Aptivus, APTIVUS
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA021814
NDA022292
ACTIVE SUBSTANCE
Tipranavir
REGULATORS
FDA · EMA
SPONSORS / MAH
Boehringer Ingelheim International GmbH, BOEHRINGER INGELHEIM
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
APTIVUSNDA021814BOEHRINGER INGELHEIMPrescription
APTIVUSNDA022292BOEHRINGER INGELHEIMDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AptivusBoehringer Ingelheim International GmbHAuthorised25/10/2005HIV Infections

FULL INTELLIGENCE ON TIPRANAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →